MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachur, N. R.
Right arrow Articles by Malkas, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachur, N. R.
Right arrow Articles by Malkas, L.

Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding

NR Bachur, R Johnson, F Yu, R Hickey, N Applegren and L Malkas

Department of Medicine, University of Maryland School of Medicine, Baltimore.

DNA-binding antibiotics such as intercalators, narrow groove binders, and other substances modify duplex DNA, making it an altered substrate for DNA helicases. The intercalators daunorubicin, actinomycin D, echinomycin, and elsamicin, the narrow groove binders distamycin and mithramycin, and the plant toxin teniposide, each representing a different chemical class, block SV40 large T antigen DNA helicase action with IC50 values ranging from 4 x 10(-8) to 2 x 10(-6) M. A partially purified human HeLa cell DNA helicase is also potently blocked by daunorubicin, distamycin, and teniposide. Because eukaryotic cells contain helicases of varying abundance, specificity, and type, this site of action for DNA-binding antibiotics may help explain antibiotic potency and specificity for DNA or RNA inhibition. The antihelicase effect of the antibiotic-double-stranded DNA complex may be central to the anticancer activities of these substances. An additional interesting correlation is the antihelicase action of DNA- intercalating antibiotics and their DNA-binding preference for G-C base pair sites. The G-C base pair binding preference of the intercalating antibiotics may result from evolutionary selection because of the higher G-C binding stability, compared with A-T binding stability. The combination of the higher base pair stability at G-C regions and increased duplex DNA stability induced by intercalating antibiotic yields a total additive stability of the intercalator-G-C base pair complex that resists helicase action.

Volume 44, Issue 5, pp. 1064-1069, 11/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
L. G. May, M. A. Madine, and M. J. Waring
Echinomycin inhibits chromosomal DNA replication and embryonic development in vertebrates
Nucleic Acids Res., January 2, 2004; 32(1): 65 - 72.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. M. Brosh Jr, J. K. Karow, E. J. White, N. D. Shaw, I. D. Hickson, and V. A. Bohr
Potent inhibition of Werner and Bloom helicases by DNA minor groove binding drugs
Nucleic Acids Res., June 15, 2000; 28(12): 2420 - 2430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Villani and N. Tanguy Le Gac
Interactions of DNA Helicases with Damaged DNA: Possible Biological Consequences
J. Biol. Chem., October 20, 2000; 275(43): 33185 - 33188.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics